Company Valuation: Kwality Pharmaceuticals Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2021 2022 2023 2024 2025 2026
Market Cap 1 581.1 6,018 3,191 4,248 9,017 13,555
Change - 935.71% -46.97% 33.12% 112.27% 50.32%
Enterprise Value (EV) 1 890.9 6,429 4,020 5,170 9,994 14,826
Change - 621.62% -37.47% 28.59% 93.32% 48.34%
P/E 3.84x 5.02x 16.5x 17.9x 22.6x 20.1x
PBR 0.95x 3.32x 1.59x 1.89x 3.42x 4.09x
PEG - 0x -0.2x 0.8x 0.3x 0.3x
Capitalization / Revenue 0.22x 1.31x 1.27x 1.38x 2.44x 2.69x
EV / Revenue 0.34x 1.4x 1.6x 1.68x 2.7x 2.95x
EV / EBITDA 2.95x 3.71x 6.52x 7.6x 12.2x 12.3x
EV / EBIT 3.76x 3.95x 8.61x 10.7x 15.7x 14.8x
EV / FCF -31x -28.5x -15.5x -39.5x -155x -27.5x
FCF Yield -3.22% -3.51% -6.43% -2.53% -0.64% -3.64%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 14.6 115.6 18.67 22.93 38.4 64.9
Distribution rate - - - - - -
Net sales 1 2,631 4,579 2,510 3,072 3,702 5,031
EBITDA 1 301.8 1,735 616.4 680.1 820.4 1,203
EBIT 1 236.9 1,628 466.8 484.5 637.5 1,005
Net income 1 151.5 1,200 193.7 238 398.5 673.5
Net Debt 1 309.8 410.6 829 921.8 976.9 1,271
Reference price 2 56.00 580.00 307.55 409.40 869.05 1,306.35
Nbr of stocks (in thousands) 10,376 10,376 10,376 10,376 10,376 10,376
Announcement Date 9/7/21 9/7/22 9/8/23 8/31/24 8/18/25 8/9/26
1INR in Million2INR
Estimates


P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 363M
35.8x12.9x27.02x0.55% 1,116B
37.07x6.25x17.38x2.11% 610B
36.17x8.31x17.13x2.45% 501B
112.15x5.92x25.35x2.35% 358B
20.49x5x12.4x2.64% 366B
21.24x5.55x13.66x2.88% 288B
22x4.43x12.71x1.99% 261B
27.56x7.08x12.68x2.32% 235B
-45.98x7.04x27.26x2.1% 195B
Average 29.61x 6.94x 18.40x 2.15% 393.01B
Weighted average by Cap. 35.04x 8.17x 19.98x 1.84%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Kwality Pharmaceuticals Limited

Historical PBR trend

Valuation ratios - PBR - Kwality Pharmaceuticals Limited

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Kwality Pharmaceuticals Limited

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Kwality Pharmaceuticals Limited

  1. Stock Market
  2. Stocks
  3. KPL Stock
  4. Valuation Kwality Pharmaceuticals Limited